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Abstract
To date, there is no quick screening test that could be used during routine office visits to accurately assess language disorders in
neurodegenerative diseases. To fill this important gap, we developed the Detection Test for Language impairments in Adults and
the Aged (DTLA), a quick, sensitive, standardized screening test designed to assess language disorders in adults and the elderly
individuals. In Study 1, we describe the development of the DTLA. In Study 2, we report data on the DTLA’s validity and reliability.
Finally, in Study 3, we establish normative data for the test. The DTLA has good convergent and discriminant validity as well as
good internal consistency and test–retest reliability. Norms for the DTLA obtained from a sample of 545 healthy, community-
dwelling, French-speaking adults from 4 French-speaking countries (Belgium, Canada (Quebec), France, and Switzerland) are
provided. The development, validation, and standardization of the DTLA constitute a significant effort to meet the need for a
language screening test adapted to neurodegenerative diseases.
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Background
The number of people aged 60 years and above is expected to at
least double by 2050, reaching approximately 2 billion older
adults worldwide.1 This dramatic demographic growth has
important economic, political, and societal implications. Nor-
mal aging is accompanied by changes in cognitive functions.
These changes do not occur in a uniform way in all cognitive
domains. Most of the cognitive changes observed in normal
aging have been attributed to a reduction in processing speed.2
Due to changes in the nervous system, older people often per-
form less well than younger adults on tests measuring attention,
working memory, episodic memory, and executive functions.3
Compared to these domains, language appears to be mostly
resistant to age-related decline in normal aging. Older adults
maintain or even improve knowledge of words and word mean-
ings.4 However, difficulties retrieving spoken and written
forms of words usually become more frequent with age.5
From a public health perspective, the demographic aging
trend is accompanied by a tremendous growth in neurodegen-
erative diseases. The number of individuals with dementia
worldwide is estimated to nearly double every 20 years, from
35.6 million in 2010 to 65.7 million in 2030 and 115.4 million
in 2050.6 Dementia is a decline in cognitive function affecting
memory, visuospatial abilities, executive functions, praxis,
gnosis, and thinking. Language is also fragile in pathological
aging. Individuals diagnosed with mild cognitive impairment,
that is, the condition between healthy aging and dementia,
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often show language deficits affecting word comprehension,
word production, syntax, and discourse (for a review, see Taler
and Phillips7). In dementia, clinical linguistic profiles have
been described following neuroepidemiological and neuropsy-
chological studies. Recent neuropsycholinguistic studies have
also made a major contribution to improving the characteriza-
tion of language deficits in dementia by specifically identifying
impaired and preserved processing components of language
processing in the early stages of the disease (for a review, see
Macoir et al8). In addition to progressive episodic memory loss,
people in the early stage of Alzheimer’s disease (AD) usually
present with semantic memory impairment leading to word-
finding and word comprehension deficits. Articulatory, phono-
logical, and syntactic abilities are usually considered unscathed
until the final stage of AD. Some studies, however, showed that
disease progression might impact these abilities.9 Syntax pro-
cessing, required for sentence production and sentence com-
prehension, may also be compromised in some cases of AD,
even in the early stages of the disease.10,11 Whether this deficit
is really syntactic in nature or is more readily explained by
working memory difficulties or semantic interpretive process-
ing remains unresolved. With respect to written language, stud-
ies in AD also reveal the presence of surface dyslexia and
surface agraphia, although different patterns of written lan-
guage impairment may also be observed. Language is also
affected in the early stages of other major forms of dementia,
including vascular cognitive impairment (VCI) and dementia
with Lewy bodies (DLB).
There are very few studies that have systematically
described language disorders in VCI. Most of them were con-
ducted in an attempt to differentiate VCI from AD. Many of
these studies suggested that there was no significant difference
in language processing between the 2 syndromes.12 However,
other authors reported contradictory results. For example,
according to most studies, the comprehension of complex sen-
tences is affected in people with VCI because of impaired
working memory and executive functions. In some of these
studies, there was little or no difference in syntactic compre-
hension between individuals with AD and VCI, while in others,
individuals with VCI performed better than those with AD.13,14
Compared to AD, the spontaneous speech of individuals with
VCI is less empty and conveys more information but they tend
to produce shorter and less grammatically complex phrases.15
To date, very little is known about the nature and prevalence of
reading and writing deficits in VCI. In newly diagnosed
patients, Chan et al16 found more reading difficulties in VCI
than in AD, while no differences between the 2 groups in
reading tasks were reported in other studies.13 For written pro-
duction, a few investigations suggest peripheral impairments
(eg, difficulties to write letters and copy sentences) in VCI.17
Others found that, as compared to individuals with AD, patients
with VCI produced more spelling errors and grammatically less
complex sentences, therefore suggesting a central origin for
this deficit.18
Dementia with Lewy bodies is a frequent form of dementia,
commonly regarded as a Parkinson plus syndrome that has the
clinical and pathological features of both AD and Parkinson
disease.19 Dementia with Lewy bodies is associated with
impairment in all areas of cognition, with predominance of
visuoperceptual/spatial deficits. Almost no study has specifi-
cally addressed language deterioration in DLB. Language is
usually considered unimpaired in the early stages of the dis-
ease but impairments in confrontation naming have been
reported with disease progression.20 Individuals with DLB
also present with syntactic impairments in sentence compre-
hension, a deficit attributed to working memory and executive
dysfunctions.21 A similar executive origin was proposed to
explain their difficulty in organizing narrative speech in both
production and comprehension modalities.22,23 Finally, up-to-
date, very little is known about the reading and spelling abil-
ities in DLB.
Finally, language deficits are at the core of the clinical por-
trait of primary progressive aphasia (PPA). Primary progres-
sive aphasia is a progressive language disorder associated with
atrophy of the frontal and temporal regions, typically resulting
from a neurodegenerative disease. Primary progressive aphasia
is a heterogeneous condition, in which the most prominent
clinical feature is difficulty with language (progressive impair-
ment of language production, syntax, or word comprehension),
while other cognitive domains, including memory, visuospatial
skills, and executive abilities, are not affected at the onset and
in the early stages of the disease.24 A broad-ranging Interna-
tional Consensus Group recently published recommendations
for the diagnosis and classification of PPA.25 These recommen-
dations provide a classification of PPA and its 3 main variants,
namely the nonfluent/agrammatic variant (nfvPPA), semantic
variant (svPPA), and logopenic variant (lvPPA). According to
this classification, at least 1 of the following 2 core features
must be present in nfvPPA: (1) effortful, halting speech with
inconsistent speech sound errors and distortions (apraxia of
speech), and (2) agrammatism in language production. More-
over, at least 2 of the following 3 additional features must be
present: (1) impaired comprehension of syntactically complex
sentences, (2) spared single-word comprehension, and (3)
spared object knowledge. The svPPA is a clinical syndrome
that results from progressive atrophy of the temporal lobes,
leading to the selective impairment of semantic memory.
According to the classification proposed by Gorno-Tempini
et al25, the following 2 core features must be present to estab-
lish a diagnosis of svPPA: (1) impaired confrontation naming
and (2) impaired single-word comprehension. Moreover, at
least 3 of the following additional features must be present:
(1) impaired object knowledge, particularly for low-
frequency or low familiarity items, (2) surface dyslexia or dys-
graphia, (3) spared repetition, and (4) spared speech production
(grammar and motor speech). Finally, the 2 core features essen-
tial to the diagnosis of lvPPA are the presence of anomia in
spontaneous speech and confrontation naming and impaired
repetition of sentences and phrases. At least 3 of the following
additional features must be present: (1) production of phono-
logical errors, (2) preservation of semantic memory, (3) pre-
servation of articulation and prosody, and (4) the absence of
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agrammatism. There are also some supporting features and
specific imaging abnormalities for each PPA variant.25
Early diagnosis of dementia relies on various types of
assessment performed to detect the disease (screening) or rule
out other possible causes of cognitive impairment (ie, differ-
ential diagnosis). With respect to cognition and language, the
main goal of screening is to determine whether a patient has a
problem or not. The output of this type of assessment is a
“pass” or “fail” result, based on an established criterion that
could lead to a more exhaustive or follow-up assessment. Cog-
nitive screening tests are used by primary care physicians to
diagnose dementia. However, this type of assessment is still not
extensively done in standard practice and numerous patients
who have dementia remain undiagnosed.26 When faced with
complex clinical presentations such as primary language symp-
toms, physicians refer patients to specialists, such as geriatri-
cians or neurologists, who also commonly use cognitive
screening tests such as the Mini-Mental State Examination
(MMSE)27, Montreal Cognitive Assessment (MoCA)28; or
Alzheimer’s Disease Assessment Scale-Cognitive Subscale
(ADAS-Cog).29 In the majority of these screening tests, the
focus of the assessment is memory dysfunction, the hallmark
of AD, while impairments in other cognitive domains such as
praxis, executive functions, and language are largely underes-
timated. However, according to the fifth edition of the Diag-
nostic and Statistical Manual of Mental Disorders,
neurocognitive dysfunction in adults is not limited to learning
and memory problems but also includes difficulties with com-
plex attention, executive functions, perceptual and motor abil-
ities, social cognition, and language.30 Moreover, studies have
shown that screening tests for dementia could be misleading
when used with patients with language problems.31
Even though most cognitive screening tests involve subtests
of language function, these are often limited to naming (eg,
MoCA) or verbal fluency (MoCA, MMSE, etc), a task mainly
relying on executive functions. Moreover, it is difficult to dis-
entangle language from other cognitive abilities. The role and
influence of language abilities in various screening tests
designed to assess cognitive functions is well known. For
example, the immediate and delayed recall of words used in
the MMSE and the MoCA to assess episodic memory rely on
verbal stimuli. Thus, these subtests also involve lexical and
semantic abilities. Impaired performance on these subtests
could originate from a memory as well as a language deficit.
Compared to the MMSE and the MoCA, a large part of Adden-
brooke’s Cognitive Examination (ACE)32 and its revised ver-
sion (ACE-R)33 is devoted to assessing language, with subtests
covering not only picture naming and verbal fluency but also
language comprehension, semantic matching, repetition, read-
ing, and spelling.19,20 The ACE-R has proven to be effective in
detecting and tracking the evolution of neurodegenerative dis-
eases in which the core symptoms are language-related, such as
nfvPPA and svPPA.34 However, considering the clinical pre-
sentation of PPA variants, some language subdomains are
missing from the ACE-R: syntactic comprehension (affected
in nfvPPA) and reading and spelling of pseudowords
(preserved in svPPA). Additionally, the ACE-R includes a sen-
tence repetition subtest but stimuli are limited to 2 short syn-
tactically complex sentences, while one of the most distinctive
features of lvPPA is impairment in the repetition of long sen-
tences because of short-term memory deficits. Finally, the
average administration time for this test is around 16 minutes,
which is lengthy for primary care clinicians.33 There are other
brief measures of cognitive status in adults, such as the Cog-
nitive Linguistic Quick Test.35 This test has similar limitations
than those described for the MMSE and the MoCA. Moreover,
its administration is lengthy (from 15 to 30 minutes) for pri-
mary care clinicians. Finally, there are some screening tests for
language impairment such as the Frenchay Aphasia Screening
Test and the Mississippi Aphasia Screening test, but they were
developed for aphasia and are not suitable for language deficits
associated with neurodegenerative diseases.36,37
As a result, primary care providers are frequently faced with
patients whose main complaints concern language problems in
everyday and professional life. To date, however, there is no
quick screening test that could be applied during routine office
visits to accurately assess language disorders in neurodegen-
erative diseases. Such a test would improve referrals to specia-
lized resources (memory clinic, geriatrics, neurology, speech-
language pathology, neuropsychology), where the diagnosis
could be confirmed and the appropriate health care provided.
Also, the use of such a test would improve the diagnosis of
neurodegenerative diseases, especially those in which language
is primarily affected. Ultimately, this will permit patients and
their families to receive services at an earlier stage of the
disease.
To fill this important gap, we developed a quick, sensitive,
standardized French screening test designed to assess language
disorders in adults and the elderly individuals. In this article,
we first describe the development of the “De´pistage des trou-
bles du langage chez l’adulte et la personne aˆge´e” (DTLA—
Detection Test for Language impairments in Adults and the
Aged), a new screening test developed in 4 French-speaking
countries (Belgium, Canada (Quebec), France and Switzer-
land). We also studied the validity and reliability of the test
and established normative data from a representative sample of
adults and elderly participants. Thus, 3 studies are presented in
this article. In Study 1, we describe the design and development
of the DTLA. In Study 2, we report data on the convergent and
discriminant validity of the DTLA as well as on its test–retest
reliability and internal consistency. Finally, in Study 3, we
provide normative data for healthy, community-dwelling,
French-speaking people from the 4 French-speaking countries.
The 3 studies were approved by the local Research Ethics
Boards of the 4 participating countries and all participants gave
their written informed consent to participate.
Study 1. Development of the DTLA
The purpose of Study 1 was to create the tasks and to choose
the stimuli of the DTLA, building on the scientific literature
and the steps for assessment tools development.
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Methods
We followed a comprehensive test development approach,
including the establishment of translational validity. Transla-
tional validity refers to the transformational aspect of construct
validity and includes content and face validity.38 The content
validity of the DTLA was established on the basis of the sci-
entific literature. The research team first identified the lan-
guage domains and abilities most frequently affected in
neurodegenerative diseases, with special attention paid to those
with the best discrimination value among clinical syndromes.
Next, the most sensitive and easy-to-use assessment tasks were
selected for each domain of interest. The research team then
determined the number of items as well as their psycholinguis-
tic characteristics in each assessment subtest, with the objective
of developing a short test, which could be administered in
approximately 5 minutes.
The following language assessment tasks were selected for
the screening test: (1) object picture naming; (2) word, non-
word, and sentence repetition; (3) verbal fluency; (4) spelling
to dictation of words and nonwords; (5) spontaneous written
sentence production; (6) reading aloud of words and nonwords;
(7) auditory sentence-to-picture matching; (8) written word
matching; and (9) alpha-span. Lexical access is consistently
affected in almost all neurodegenerative diseases. Deficits in
this domain lead to substantial difficulties in confrontation
naming, which is why a spoken picture-naming task was cho-
sen. A phonemic verbal fluency task was also selected to assess
lexical access. This task requires the generation of a lexical
strategy, sustained by executive functions, which guides the
search for words in the mental lexicon. Impairment in phone-
mic verbal fluency has been consistently reported in the major-
ity of neurodegenerative diseases, including the 3 PPA
variants.39,40 Performance on sentence repetition tasks is essen-
tial to differentiate lvPPA from the 2 other PPA variants. More-
over, apraxia of speech, which is 1 of the 2 core features of
nfvPPA, could be exacerbated in nonword and sentence repeti-
tion tasks and helped to differentiate individuals with nfvPPA
presenting with apraxia of speech from those with agramma-
tism.41 A word, nonword, and sentence repetition tasks were
therefore selected. Impairment of written production abilities
usually occurs very early in the course of the majority of neu-
rodegenerative diseases (for a review, see Macoir et al8). For
example, individuals with AD or svPPA often develop surface
dysgraphia.42,43 Dysgraphia involves written agrammatism and
the production of nonphonologically plausible paragraphias in
nfvPPA, while patients with lvPPA usually present with pho-
nological dysgraphia.44,45 Spontaneous writing may also be
affected in neurodegenerative diseases.46,47 Impairment in this
task usually mimics the manifestations observed in spoken
production (ie, difficulties in lexical access, inflectional mor-
phology, syntactic structure). A task involving spelling to dic-
tation of words and nonwords and a spontaneous written
sentence production task were selected to assess written pro-
duction abilities. Reading difficulties are key features in AD
and PPAs. They are observed in AD and svPPA in the form of
surface dyslexia. In nfvPPA, disease progression is sometimes
accompanied by the production of phonological errors in read-
ing, while a pattern of phonological dyslexia is observed in
lvPPA.41,48 A word and nonword reading aloud tasks were
chosen to assess reading. Sentence comprehension is another
domain that can be compromised in neurodegenerative dis-
eases. Deficits in this domain have been reported in cases of
AD and Lewy body dementia, even in the early stages of the
disease.10,21 The impaired comprehension of syntactically
complex sentences is 1 of the 3 additional features that must
be present to detect nfvPPA.25 Moreover, impairment in sen-
tence comprehension was also found in lvPPA patients due to a
reduction in verbal short-term memory resources.49 A syntac-
tically complex sentence-to-picture matching task was chosen
to assess sentence comprehension. Also, semantic processing is
consistently affected in AD.50 Semantic impairment is also at
the core of the clinical manifestations of svPPA, while seman-
tic processing is preserved in the other 2 PPA variants.25 A
semantic written word-matching task was selected to assess
semantic processing. Finally, some of the language deficits
observed in neurodegenerative diseases are caused by phono-
logical short-term memory and/or verbal working memory
impairments. Such an origin was posited to explain difficulties
in sentence production and sentence comprehension observed
in AD and Lewy body dementia.10,21 Reduction in phonologi-
cal short-term memory resources was also proposed to account
for the deficit in sentence repetition and sentence comprehen-
sion in lvPPA.25,49 An alphabetization span task (“alpha-span
task”), which requires subjects to recall presented words in
alphabetical order, was selected to assess phonological short-
term/working memory. Phonology is usually preserved in the
early stages of AD, VCI, and DLB. As mentioned above, pho-
nological abilities are affected in nfvPPA and lvPPA. In the
DTLA, phonological impairment can be identified in all subt-
ests involving spoken production: picture naming, word, non-
word, and sentence repetition, verbal fluency, and word and
nonword reading aloud. The cognitive domains, tasks, and
characteristics of the items chosen as a result of the develop-
ment process are presented in Table 1.
Once the tasks and items were chosen, a pilot study was
conducted to develop the final version of the DTLA. A screen-
ing test with 4 times as many stimuli as required for the final
version of the test was created (except for verbal fluency, spon-
taneous writing and alpha-span: 2 three-item lists, 1 four-item
list, and 1 five-item list). This preliminary version also com-
prised the administration protocol for each subtest including
the language domain assessed, the stimuli, the psycholinguistic
variables controlled and manipulated, and the instructions.
Clinical experts then reviewed this version to establish the
instrument’s face validity. A total of 18 professionals in the 4
countries (1 geriatrician, 2 neurologists, 7 neuropsychologists,
1 psychiatrist, and 7 speech-language pathologists) were
invited to review the preliminary version of the DTLA by
means of a questionnaire specifically developed to evaluate its
appropriateness, usefulness, ease-of-use, and clarity (adminis-
tration sheet, instructions). All informants agreed
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wholeheartedly with the purpose and usefulness of the instru-
ment. After their review, adjustments were made to all the
elements where a lack of clarity in the instructions or the pro-
cedure was identified.
Following these adjustments, the preliminary version of the
DTLA was administered to 106 healthy participants (normal
age- and education-adjusted MMSE scores) in the 4 French-
speaking countries (Belgium ¼ 40, France ¼ 25, Canada ¼ 23,
Switzerland ¼ 18) in order to proceed to the final selection of
stimuli. All participants spoke French as their primary lan-
guage. Their mean age was 65.2 years (SD ¼ 9.5, range ¼
50-88), their mean level of education was 12.56 years (SD ¼
3.34, range ¼ 6-23), and the gender distribution was 37 males
and 69 females. They all self-reported good mental and phys-
ical health (ie, no history of neurological disease, current
untreated psychiatric illness, traumatic brain injury or untreated
medical conditions that could interfere with cognitive perfor-
mance). All participants were tested individually in a quiet
room at their home or one of the participating research centers,
and the tasks were administered without any time constraints.
For the final selection of stimuli, the items kept were those
for which the best scores were obtained in the 4 countries. The
average success rates for each task were as follows: object
picture naming ¼ 99.83% (SD ¼ .41); repetition: words ¼
100%, nonwords ¼ 95% (SD ¼ 3.61), and sentences ¼ 87%
(SD ¼ 6.24); spelling to dictation: words ¼ 91.33% (SD ¼
3.39), nonwords ¼ 96.67% (SD ¼ 3.2); reading aloud: words
and nonwords ¼ 100%; auditory sentence-to-picture matching
¼ 100%; written word matching ¼ 100%. On average, the
participants produced 12.31 (SD ¼ 1.35) words beginning with
Table 1. Cognitive Domains, Tasks, Item Characteristics, and Scoring of the DTLA.
Cognitive Domain Task
Item Characteristics
(Number of Stimuli) Psycholinguistic Variables Scoring
Lexical access in
production
Picture naming  Pictures (6)  Semantic category: biological concepts
(3); man-made concepts (3)
 Lexical frequency: low
 Subjective frequency: low
2 points/item:
12 points
Spoken production
and phonological
short-term memory
Repetition  Words (3)
 Nonwords (3)
 Long sentences (3)
 Phonological complexity: high
 Syllable length (words and nonwords: 3
syll; sentences: 2  17 and 1  18 syll.)
2 points/item:
18 points
Spoken production
and executive
functions
Verbal fluency  Phonemic verbal fluency
with letter D in 1
minute
15 points:
EL 11 years ¼
8 words
EL 12 years ¼
10 words
Written production Spelling to
dictation
 Words (3)
 Nonwords (3)
 Words: lexical frequency: low;
orthographic complexity: irregular
 Syllable length (words: 2 syll;
nonwords: 1 syll)
2 points/item:
12 points
Spontaneous
writing
 Written sentence
spontaneous
production (subject–
verb complement)
4 points
Lexical and nonlexical
reading
Reading aloud  Words (3)
 Nonwords (3)
 Lexical frequency: low
 Orthographic complexity: irregular
words
 Syllable length (words and nonwords:
2 syll)
1 point/item:
6 points
Syntactic
comprehension
Auditory
sentence-to-
picture
matching
 Syntactically complex
reversible sentences (3)
 Syntactic structure: cleft object
sentence (1); agentless passive
sentence (1); passive sentence with
agent (1)
4 points/item:
12 points
Semantic memory Written word
matching
 Word triplets (4)  Semantic category: biological concepts
(2); man-made concepts (2)
 Semantic relationship: associative (2);
categorial (2)
4 points/item:
16 points
Verbal working
memory
Alpha-span  Word triplet (1)  Lexical frequency: high
 Syllable length: 1 syll
 Imageability: high
5 points
Abbreviations: DTLA, Detection Test for Language impairments in Adults and the Aged; EL, education level.
5
the letter D in the fluency task. In 96.33% (SD¼ 3.51) of them,
the spontaneous production of a sentence was correct. Finally,
for the alpha-span, the average success rates were low for the
4-item (47%, SD¼ 10.47) and 5-item (11%, SD¼ 3.7) lists, so
the 3-item list was retained (95%, SD ¼ 5.97).
The final version of DTLA is presented on a single double-
sided sheet held in portrait orientation. The 5 of the 6 pictures in
the naming task were taken from the study of Snodgrass and
Vanderwart51, and 1 was taken from the study of Bonin et al,
while the picture for the auditory sentence-to-picture matching
task is original artwork.38,52 The psycholinguistic parameters
controlled and manipulated in the final version of the test are
presented in Table 1. Data for lexical frequency were taken from
the study ofNew53 and those for subjective frequency and image-
ability were taken from the study of Desrochers and Bergeron.54
The scoring method was established according to the relative
value of each subtest for the detection of language impairment for
a totalmaximum score of 100 points.We chose to use a 100-point
scale for 2 reasons. First, its use and interpretation are more intui-
tive (ie, people are used to considering 100 points a perfect score).
Second, it enabled us to better distribute the relative weight of
each subtest in the total score by avoiding the usage of decimals.
The scoring method and the maximum score for each subtest are
presented in Table 1. Each item was allotted a number of points,
except for verbal fluency for which fifteen points are given
according to the following cutoff scores for 2 education levels,
calculated on the basis of data collected in the normative study
(see below): production of 8words for individualswho have 11 or
fewer years of formal education and production of 10 words for
individualswith 12ormore years of formal education.TheDTLA
protocol, administration procedure, and instructions are available
upon request from the first author.
Study 2. Validity and Reliability of the DTLA
The purpose of Study 2 was to provide data on the DTLA’s
convergent and discriminant validity as well as on its test–
retest reliability and internal consistency. The DTLA was
designed to assess language impairment in neurodegenerative
diseases. However, it is conceivable that it could also be used to
detect language deficits in other neurological populations.
Therefore, convergent validity, discriminant validity, and inter-
nal consistency were established by including participants pre-
senting with neurodegenerative diseases and participants with
post-stroke aphasia. A schematic representation of the DTLA
validation process is presented in Figure 1.
Methods
Participants, materials, and procedure. In all the studies of the
psychometric properties of the DTLA hereafter described, par-
ticipants were tested individually in a quiet room at their home
or at one of the participating research centers. The external
measures (ie, the other tests) and the DTLA were administered
without any time constraints. Written protocols for the tests
were collected by research assistants.
Convergent validity. Thirty-one patients were recruited.
Twenty patients had a diagnosis of probable AD (mean age
¼ 77.75, SD ¼ 7.85 years; mean education ¼ 13, SD ¼ 3
years; mean MMSE score ¼ 21.10, SD ¼ 4.15). Probable
AD was determined according to current diagnostic criteria and
based on medical records and history (eg, diagnosis of AD from
a medical doctor and/or participants taking an approved phar-
macological treatment for dementia [memantine, donepezil,
galantamine, or rivastigmine]).55 These patients were in the
mild-to-moderate stage of AD. Seven patients had chronic
(ie, more than 1 year post-stroke) aphasia (mean age ¼
66.29, SD ¼ 9.25 years; mean education ¼ 13, SD ¼ 3.26
years; mean MMSE score ¼ 21.29, SD ¼ 4.35), and 4 patients
had been diagnosed by a neurologist with PPA (nonfluent/
agrammatic variant ¼ 2; logopenic variant ¼ 1; semantic var-
iant ¼ 1) over the last 2 years (mean age ¼ 76, SD ¼ 7 years;
mean education ¼ 9, SD ¼ 3.47 years; mean MMSE score ¼
23, SD ¼ 3). Primary progressive aphasia was determined
according to current diagnostic criteria and based on medical
records and history (eg, diagnosis from a neurologist).25 Exclu-
sion criteria for all participants were as follows: (1) history of
moderate or severe traumatic brain injury, (2) history of cere-
brovascular disease (this criterion did not apply to post-stroke
aphasia patients), (3) history of delirium (in the last 6 months),
(4) history of intracranial surgery, (5) history of neurological
disorder of cerebral origin (other than those examined in the
study), (6) history of encephalitis or bacterial meningitis, (7)
unstable metabolic or medical condition (eg, untreated
hypothyroidism or diabetes), (8) history or actual psychiatric
diagnosis according to the DSM-V,30 (9) alcoholism or sub-
stance abuse (in the last 12 months), (10) uncorrected vision or
Figure 1. Schematic representation of the Detection Test for Lan-
guage impairments in Adults and the Aged (DTLA) validation process.
AD indicates Alzheimer’s disease; BNT, Boston Naming Test; HC,
healthy control; MEC, Protocole Montre´al d’E´valuation de la Com-
munication; MT-86, Protocole Montre´al-Toulouse d’examen linguis-
tique de l’aphasie; PPA, primary progressive aphasia; PPTT, Pyramids
and Palm Trees Test; WMS, Wechsler Memory Scale.
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audition problems, and (11) inability of the participant to pro-
vide consent due to inaptitude.
The following tests were administered to all the participants:
the DTLA, Boston Naming Test;56 repetition, comprehension,
reading, spelling, and written questionnaire subtests of the Pro-
tocole Montre´al-Toulouse d’examen linguistique de l’aphasie
(MT-86); fluency subtest of the Protocole Montre´al d’E´valua-
tion de la Communication (MEC); digit span subtest of the
Wechsler Memory Scale—Fourth Edition; and Pyramids and
Palm Trees Test.57-60 The association of the performance of the
participants on the different tasks was analyzed using Pearson
correlation coefficients.
Discriminant validity. We tested whether the DTLA score dis-
tinguished between the performances of controls and patients
with AD in the mild to moderate stage of the disease and
between the performances of controls and patients with chronic
post-stroke aphasia. Inclusion and exclusion criteria of partici-
pants were identical than those used for convergent validity. To
do so, 2 groups were compared by means of independent sam-
ples t tests: (1) a group of 12 patients with a diagnosis of
probable AD, matched to a group of 24 healthy control parti-
cipants by age (AD: mean age ¼ 74.5, SD ¼ 4.83 years; Con-
trols: mean age ¼ 73.5, SD ¼ 5.24 years; t (34) ¼ .553, P ¼
.58) and education (AD: mean education ¼ 13.58, SD ¼ 3.06
years; Controls: mean education ¼ 13.71, SD ¼ 3.71 years; t
(34) ¼ .101, P ¼ .92) and (2) a group of 12 patients with post-
stroke aphasia, matched to a group of 24 healthy control parti-
cipants by age (aphasia: mean age ¼ 62.67, SD ¼ 6.44 years;
Controls: mean age ¼ 64.33, SD ¼ 5.80 years; t (34) ¼ .784, P
¼ .44) and education (aphasia: mean education ¼ 12.08, SD ¼
2.87 years; Controls: mean education ¼ 12.08, SD ¼ 3.84
years; t (34) < .001, P ¼ .1). Both groups of patients differed
significantly from controls in terms of their score on the MMSE
(AD: mean score ¼ 21.42, SD ¼ 3.73; Controls: mean score ¼
28.42, SD¼ 1.35; t (34)¼ 8.27, P < .001; Aphasia: mean score
¼ 24.25, SD¼ 4.58; Controls: mean score¼ 28.42, SD¼ 1.18;
t (34) ¼ 4.24, P < .001).
Test–retest reliability. The DTLA was administered twice to
twenty healthy participants (mean age at first testing ¼ 62.4,
SD ¼ 6.73 years; mean education ¼ 12.7, SD ¼ 2.87 years;
mean MMSE score ¼ 28.55, SD ¼ 1.73) with a 6-month inter-
val. The 2 measures (T1 and T2) were compared by means of a
paired samples t test.
Internal consistency. This type of reliability was studied with a
sample of 602 participants divided into 4 groups: (1) healthy
controls (n ¼ 561; mean age ¼ 63.96, SD ¼ 9.21 years; mean
education ¼ 12.5, SD ¼ 3.39 years; mean MMSE score ¼
28.53, SD ¼ 1.30), (2) patients with AD (n ¼ 20; mean age
¼ 77.75, SD¼ 7.85 years; mean education¼ 13.15, SD¼ 3.07
years; mean MMSE score ¼ 21.10, SD ¼ 4.15), (3) patients
with post-stroke aphasia (n ¼ 17; mean age ¼ 68.06, SD ¼
10.86 years; mean education ¼ 11, SD ¼ 3.20 years; mean
MMSE score ¼ 22.71, SD ¼ 6.14), and (4) patients with PPA
(n ¼ 4; mean age ¼ 76, SD ¼ 7.07 years; mean education ¼ 9,
SD ¼ 3.46 years; mean MMSE score ¼ 23, SD ¼ 3). Internal
consistency was calculated by means of the Cronbach a
coefficient.
Results
Convergent Validity
Table 2 shows the correlation matrix between the external
measures and DTLA subtests. The relevant correlations are
highlighted in gray. As expected, the external measures that
assessed the same construct correlated significantly and
Table 2. Correlations Between External Measures and DTLA Subtests for Convergent Validity.
External Measures
DTLA Subtests
Boston
Naming Test
Repetition
(MT-86)
Fluency
(MEC)
Span Task
(WMS-IV)
Reading
(MT-86)
Comprehension
(MT-86)
Spelling to
Dictation
(MT-86)
Written
Questionnaire
(MT-86) PPTT
Object picture naming .817a,b .127 .102 .282 .249 .319 .326 .307 .487b
Repetition .330 .788a,b .476b .605b .735b .707b .691b .481b .215
Fluency .266 .247 .733a,b .681b .348 .581b .546b .413c .140
Alpha-span .220 .225 .151 .228a .171 .141 .132 .200 .227
Reading .295 .681b .486b .603b .846a,b .758b .802b .730b .206
Auditory sentence-to-picture
matching
.239 .332 .105 .213 .255 .378a,c .147 .011 .464b
Spelling to dictation .487b .661b .442c .608b .895b .734b .922a,b .853b .044
Spontaneous sentence
production
.132 .389c .613b .311 .389c .482b .412c .510a,b .135
Written word matching .510a,b .148 .161 .081 .012 .013 .138 .258 0.301a
Abbreviations: DTLA, Detection Test for Language impairments in Adults and the Aged; MEC, Protocole Montre´al d’E´valuation de la Communication; MT-86,
Protocole Montre´al-Toulouse d’examen linguistique de l’aphasie; PPTT, Pyramids and Palm Trees Test.
aIndicates relevant correlations.
bP < .01.
cP < .05.
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positively with the corresponding DTLA subtests, except for 2
of them. First, the Pyramids and Palm Trees Test did not cor-
relate significantly with the written word matching subtest of
the DTLA, even though both tests focus on semantic process-
ing.60 However, the Boston Naming Test, which also includes
semantic processing, and the written word matching DTLA
subtest correlated positively and significantly.56 Second, the
digit span subtest of the Wechsler Memory Scale—Fourth Edi-
tion and the alpha-span subtest of the DTLA, both measures of
working memory, failed to show a significant correlation.59
Discriminant Validity
The mean DTLA score of patients with AD was significantly
lower than that of healthy controls (AD: mean score ¼ 81.75,
SD ¼ 15.51; Controls: mean score ¼ 95.17, SD ¼ 5.78; t (34)
¼ 4.43, P < .001). Also, the mean DTLA score of patients with
post-stroke aphasia was significantly lower than that of healthy
controls (Aphasia: mean score ¼ 58.83, SD ¼ 15.46; Controls:
mean score ¼ 93.79, SD ¼ 8.20; t (34) ¼ 8.92, P < .001).
Test–Retest Reliability
The performance of healthy controls on the DTLA did not
differ between the first (T1) and second testing (T2), conducted
6 months after the first (T1 mean score¼ 94.10, SD¼ 7.36; T2
mean score ¼ 96.20, SD ¼ 5.56; t (19) ¼ 1.63, P ¼ .12).
Internal Consistency
The Cronbach a coefficient obtained was .84 for the 36 ele-
ments that make up the DTLA’s stimuli (except for fluency
since it does not have values of 0 or 1 but is composed of the
number of words produced by participants). According to Cor-
tina61, a coefficient between .8 and .9, like the one we found, is
considered to indicate good internal consistency.45
Summary
From the analyses carried out, we can conclude that, overall,
the DTLA has good convergent validity. The screening test can
also distinguish between the performance of controls and
patients with AD and controls and patients with post-stroke
aphasia and therefore presents good discriminant validity. The
stability of the DTLA over time is good (test–retest reliability)
as is its internal consistency.
Study 3. Normative Data
The purpose of Study 3 was to provide normative data for the
DTLA, adapted to adult and aged populations from the 4
French-speaking countries.
Method
Participants. A total of 545 healthy, community-dwelling,
French-speaking adults, whose mother tongue and currently
used language was French, were recruited in the 4 French-
speaking countries (Belgium: n ¼ 76, 13.09%; Quebec,
Canada: n ¼ 99, 18.2%; France: n ¼ 255, 46.8%; Switzerland:
n ¼ 115, 21.1%). All participants had normal age- and
education-adjusted MMSE scores (MMSE 26; mean score
¼ 28.54, SD ¼ 1.3), indicating normal cognition.27 All parti-
cipants self-reported good mental and physical health (ie, no
history of neurological disease, current untreated psychiatric
illness, traumatic brain injury, or untreated medical condition
that could interfere with cognitive performance).
The sample was composed of 235 men (43%) and 310
women (57%), aged between 50 and 80 (mean age ¼ 63.32
years, SD ¼ 8.53 years), with an education level varying
between 2 and 26 years (mean education ¼ 12.5 years, SD ¼
3.37 years). Based on the education systems of the 4 countries
and in previous experiences with tests for French-speaking
populations, participants were recruited by speech-language
pathology students through public advertisements and among
relatives to form 4 mutually exclusive age and education
groups: (1) 50 to 64 years of age and 11 or fewer years of
formal education, (2) 50 to 64 years of age and 12 or more
years of formal education, (3) 65 to 80 years of age and 11 or
fewer years of formal education, and (4) 65 to 80 years of age
and 12 or more years of formal education. Table 3 shows the
descriptive statistics of the 4 groups of participants for the
normative study as a function of age and education.
Materials and procedure. All participants were tested individu-
ally in a quiet room at their home or a research center. Tasks
Table 3. Descriptive Statistics (Mean and Standard Deviation) of the
4 Groups of Participants for the Normative Study as a Function of Age
(65 and 65þ Years) and Education (11 and 12þ Years).a
Age
50-64 years 65-80 years
Education Education
11 years 12þ years 11 years 12þ years
Mean SD Mean SD Mean SD Mean SD
Age 57.45 4.42 55.93 3.95 71.74 4.73 70.45 4.83
Education 9.86 1.77 14.81 2.42 9.40 1.43 15.04 2.47
% Women 59 54 63 53
N 126 166 124 129
DTLA 93.88 6.99 97.73 4.19 91.58 8.23 96.35 5.88
Alert 84 94 83 92
Cutoff 78 85 75 81
Total N 545
aSD, standard deviation; Age, age in years; Education, formal education in
years; Women, percentage of women; N, number of participants in the group;
DTLA, Detection Test for Language impairments in Adults and Aged people
score/100; Alert, suggested alert score calculated as the 15th percentile
(score below it and above the cutoff may indicate “at risk”); Cutoff, suggested
cutoff score calculated as the fifth percentile (score equal to or below it is
under normal performance limits); Total N, total number of participants in
the normative study.
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were administered without any time constraints. All of the
DTLA’s visual stimuli (pictures, written words) were presented
on the test sheet. Written protocols for the tests were collected
by research assistants and data were entered in the analyses.
Results
Two-way analyses of variance (ANOVA) were carried out with
age (65 and 65þ years) and education (11 and 12þ years)
as between-subject factors and the total score on the DTLA
(max 100 points) as the dependent variable. Results showed
that age, F (1, 541)¼ 11.28, P < .01, Z2¼ .020, and education,
F (1, 541) ¼ 61.84, P < .001, Z2 ¼ .10, significantly affected
performance on the DTLA. The interaction of age x education
did not reach significance, with F (1, 541) ¼ .70, P ¼ .40.
We calculated the 5th, 15th, 25th, and 50th percentiles for
the DTLA score for each group. After visual exploration of the
whisker plots and according to the usual criteria,62 we chose the
fifth percentile, which approximately corresponds to one and a
half standard deviations below the mean, as the most reliable
cutoff score.63 A score equal to or below the suggested cutoff
score can be considered to be under normal performance limits.
We also proposed an alert score based on the 15th percentile,
frequently considered as representing borderline perfor-
mance.64 A score below this alert score is not necessarily, but
might be, under normal performance limits. Further language
and cognitive testing is suggested in such cases. Table 3 shows
the suggested cutoff and alert scores for each group of partici-
pants. The average time to administer the DTLA is about 5
minutes. Scoring is performed as the test is administered, so
that the average time to complete the DTLA (ie, administration,
scoring and interpretation) is about 6 minutes.
Discussion
Aging is the most important risk factor for cognitive decline,
and the detection of cognitive impairment in at-risk middle-
aged and elderly individuals has become a societal priority. In
frontline services as well as specialized clinics, this detection is
done by means of cognitive screening tests such as the MMSE
or MoCA.27,28 In the majority of these tests, the assessment
focuses on memory dysfunction, the hallmark of AD, while
other cognitive domains such as praxis, executive functions
and language are largely ignored. Furthermore, studies have
shown that screening tests for dementia could be misleading
when used with patients with language problems.31 Language
deficits are an integral part of clinical symptoms in all the
major forms of neurodegenerative diseases. They are also the
core features of the 3 variants of PPA. Most cognitive screening
tests involve subtests of language function (eg, picture naming
in MoCA, verbal fluency in MoCA and MMSE). However,
these tests are not sensitive enough to capture the entire spec-
trum of language manifestations in dementia or they are too
time-consuming to administer (eg, ACE-R33) for them to be
used in primary care services.20 In short, there is no quick,
sensitive screening test that could be administered during
routine office visits to assess language deficits in neurodegen-
erative diseases.
The DTLA was explicitly developed to meet the need for an
assessment tool specifically addressing the language impair-
ment encountered in the majority of neurodegenerative dis-
eases. This test comprises 9 sensitive, easy-to-administer
tasks designed to quickly (5 minutes) assess the language
domains and abilities most frequently affected in these dis-
eases, with particular attention paid to those with the best dis-
crimination value among clinical syndromes. The results of the
psychometric study of this new tool showed that it has good
convergent and discriminant validity as well as very good inter-
nal consistency and test–retest reliability. This study also pro-
vides norms for the DTLA obtained from a sample of 545
healthy, community-dwelling, French-speaking adults. These
individuals, aged between 50 and 80 years, with an education
level varying between 2 and 26 years, were recruited in 4
French-speaking countries (Belgium, Canada (Quebec),
France, and Switzerland). The development, validation, and
standardization of such a screening instrument constitute a sig-
nificant effort to meet the need for a language screening test
adapted to neurodegenerative diseases.
As a screening test, the main goal of the DTLA is to deter-
mine whether an individual has language impairment.
Although scores on specific subtests can provide information
concerning the possible etiology of deficits, the tests were not
designed to make differential diagnoses. The suggested cutoff
and alert scores provided in this study for the DTLA should be
used, respectively, to confirm the presence of a language
impairment or to raise a flag and prompt further and more
extensive language assessment. Other information collected
during the medical visit may supplement the DTLA results, for
example, specific complaints about language, word finding,
speech, or syntactic problems apparent during the interview.
The large group of participants is a major strength of this
normative study. Despite this significant number, however,
further studies are needed to, for example, extend the DTLA
normative data to include people aged 81 and above. Another
limitation of the present study was the use of an incidental
sampling method, which could have resulted in selection bias.
Although a random sampling method would have been prefer-
able, this study is a practical and relevant starting point for
establishing DTLA norms for the French-speaking population.
Culture has an impact on cognition, and therefore, it is impor-
tant to use normative data specific to the population to which
they are applied. This is particularly true for the assessment of
language functions, considering the possible psycholinguistic
(eg, vocabulary, familiarity of concepts) biases. The DTLA was
created by selecting stimuli culturally adapted to the populations
in the 4 French-speaking countries. Further studies are now nec-
essary to develop DTLA versions in other languages.
Conclusion
To conclude, this study provides psychometric and normative
data for the DTLA, a new screening test for the quick
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assessment of language abilities in adults and elderly people.
These norms, established from a wide sample of individuals
selected from the community in 4 French-speaking countries,
will be useful to primary care and specialized clinicians in
detecting language impairments associated with neurodegen-
erative diseases.
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